BiomX Inc. (PHGE)

BiomX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	44.12	15.86	32.29	63.1	37.24	72.41
Short-Term Investments	0	0	2	0	19.85	10
Cash & Cash Equivalents	44.12	15.86	34.29	63.1	57.09	82.41
Cash Growth	45.58%	-53.74%	-45.65%	10.52%	-30.73%	107.34%
Other Current Assets	2.99	1.77	2.59	3.54	3.58	2.12
Total Current Assets	47.1	17.63	36.88	66.64	60.67	84.53
Property, Plant & Equipment	18.72	7.4	8.65	9.83	6.66	3.03
Goodwill and Intangibles	0	0	0	1.52	3.04	0
Other Long-Term Assets	15.79	0	0	0	0	4.56
Total Long-Term Assets	34.51	7.4	8.65	11.35	9.7	7.59
Total Assets	81.61	25.03	45.53	77.99	70.36	92.12
Accounts Payable	9.72	4.73	2.97	8.25	6.3	5.85
Deferred Revenue	0	0	0	1.98	0	0
Current Debt	0.99	6.45	4.97	0.82	0.86	0.38
Total Current Liabilities	10.71	11.18	7.94	11.04	7.16	6.22
Long-Term Debt	9.14	8.64	14.39	19.2	5.03	0.86
Other Long-Term Liabilities	71.3	2.13	2.16	0.22	0.7	0.59
Total Long-Term Liabilities	80.44	10.77	16.55	19.41	5.73	1.44
Total Liabilities	91.15	21.95	24.49	30.46	12.89	7.67
Total Debt	10.12	15.09	19.36	20.02	5.9	1.23
Debt Growth	-46.09%	-22.04%	-3.29%	239.54%	378.88%	-
Retained Earnings	-180.3	-162.97	-136.8	-108.48	-72.26	-42.17
Shareholders' Equity	-9.54	3.08	21.04	47.54	57.47	84.46
Net Cash / Debt	33.99	0.77	14.94	43.08	51.2	81.18
Net Cash / Debt Growth	194.96%	-94.83%	-65.33%	-15.85%	-36.94%	104.24%
Net Cash Per Share	0.55	0.02	0.50	1.66	2.22	14.46
Working Capital	36.39	6.46	28.94	55.6	53.51	78.31
Book Value Per Share	-0.15	0.06	0.70	1.83	2.49	15.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).